<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>6931212</pmcid><all-ids><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmid">31869768</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmc">6931212</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="publisher-id">S2213-1582(19)30477-2</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="doi">10.1016/j.nicl.2019.102130</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="publisher-id">102130</article-id></all-ids><extracted-table><table-id>tbl0001</table-id><table-label>Table 1</table-label><table-caption>The demographic and clinical information of all participants.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" position="float" id="tbl0001"><label>Table 1</label><caption><p>The demographic and clinical information of all participants.</p></caption><alt-text id="alt0004">Table 1</alt-text><table frame="hsides" rules="groups"><tbody><tr><td valign="top"/><td valign="top">D-PD (<italic>n</italic> = 59)</td><td valign="top">ND-PD (<italic>n</italic> = 97)</td><td valign="top">HC (<italic>n</italic> = 45)</td><td valign="top">P value</td></tr><tr><td valign="top">Age (years)</td><td valign="top">57.6 ± 10.7 (41 - 75)</td><td valign="top">61.2 ± 9.5 (44 - 79)</td><td valign="top">59.4 ± 10.0 (45 - 75)</td><td valign="top">0.092<xref rid="tb1fn1" ref-type="table-fn">*</xref><sup>,</sup><xref rid="tb1fn4" ref-type="table-fn">a</xref></td></tr><tr><td valign="top">Sex (M/FM)</td><td valign="top">28/31</td><td valign="top">51/46</td><td valign="top">24/21</td><td valign="top">0.77<xref rid="tb1fn2" ref-type="table-fn">†</xref></td></tr><tr><td valign="top">PD duration (years)</td><td valign="top">9.5 ± 2.9 (5 - 14)</td><td valign="top">7.8 ± 2.4 (5 - 12)</td><td valign="top">NA</td><td valign="top">0.001<xref rid="tb1fn3" ref-type="table-fn">‡</xref></td></tr><tr><td valign="top">LEDD</td><td valign="top">1056.4 ± 483.6 (250 - 1750)</td><td valign="top">1004.8 ± 452.9 (250 - 1750)</td><td valign="top">NA</td><td valign="top">0.43<xref rid="tb1fn3" ref-type="table-fn">‡</xref></td></tr><tr><td valign="top">UPDRS III</td><td valign="top">46.4 ± 15.2 (30 - 81)</td><td valign="top">44.6 ± 13.5 (23.5 - 76)</td><td valign="top">NA</td><td valign="top">0.48<xref rid="tb1fn3" ref-type="table-fn">‡</xref></td></tr><tr><td valign="top">HDRS</td><td valign="top">24.1 ± 10.5 (12 - 54)</td><td valign="top">13.9 ± 6.7 (2 - 24)</td><td valign="top">6.7 ± 4.6 (0 - 15)</td><td valign="top">&lt; 0.001<xref rid="tb1fn1" ref-type="table-fn">*</xref><sup>,</sup><xref rid="tb1fn5" ref-type="table-fn">b</xref></td></tr><tr><td valign="top">BDI</td><td valign="top">21.5 ± 11.1 (9 - 48)</td><td valign="top">8.1 ± 6.2 (2 - 20)</td><td valign="top">4.9 ± 3.5 (0 - 12)</td><td valign="top">&lt; 0.001<xref rid="tb1fn1" ref-type="table-fn">*</xref><sup>,</sup><xref rid="tb1fn5" ref-type="table-fn">b</xref></td></tr><tr><td valign="top">PSQI</td><td valign="top">15.7 ± 8.4 (4 - 34)</td><td valign="top">14.2 ± 7.6 (2 - 32)</td><td valign="top">12.7 ± 6.7 (1 - 26)</td><td valign="top">0.14<xref rid="tb1fn1" ref-type="table-fn">*</xref><sup>,</sup><xref rid="tb1fn4" ref-type="table-fn">a</xref></td></tr><tr><td valign="top">MoCA</td><td valign="top">23.1 ± 5.4 (14 - 30)</td><td valign="top">24.2 ± 4.6 (15 - 30)</td><td valign="top">26.9 ± 2.4 (26 - 30)</td><td valign="top">&lt; 0.001<xref rid="tb1fn1" ref-type="table-fn">*</xref><sup>,</sup><xref rid="tb1fn6" ref-type="table-fn">c</xref></td></tr><tr><td valign="top">MMSE</td><td valign="top">26.9 ± 3.1 (20 - 30)</td><td valign="top">27.6 ± 2.8 (22 - 30)</td><td valign="top">28.2 ± 2.1 (26 - 30)</td><td valign="top">0.065<xref rid="tb1fn1" ref-type="table-fn">*</xref><sup>,</sup><xref rid="tb1fn4" ref-type="table-fn">a</xref></td></tr></tbody></table><table-wrap-foot><fn id="spara005"><p>BDI = Beck Depression Inventory, D-PD = depressed PD, FM = female, HC = healthy controls, HDRS = Hamilton Depression Rating Scale, LEDD = levodopa equivalent daily dose, <italic>M</italic> = male, MMSE = Mini-Mental State Examination, MoCA = Montreal Cognitive Assessment Scale, NA = not applicable, ND-PD = non-depressed PD, PSQI = Pittsburgh Sleep Quality Index, UPDRS III = Unified Parkinson's Disease Rating Scale part III.</p></fn><fn id="spara006"><p>Values are represented as the mean ± standard deviation with the range in parentheses, except for the gender distribution. For comparisons of demographic and clinical characteristics:.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tb1fn1"><label>⁎</label><p id="notep0004">P values were calculated with One-way ANOVA tests.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tb1fn2"><label>†</label><p id="notep0005">P value was obtained using a chi-squared test.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tb1fn3"><label>‡</label><p id="notep0006">P values were calculated with two-tailed t tests.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tb1fn4"><label>a</label><p id="notep0007">Post-hoc paired comparisons showed no significant differences between each two of the three groups.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tb1fn5"><label>b</label><p id="notep0008">Post-hoc paired comparisons showed significant differences between each two of the three groups.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tb1fn6"><label>c</label><p id="notep0009">Post-hoc paired comparisons showed significant differences between D-PD and HC, and between ND-PD and HC. <italic>P</italic> &lt; 0.05 was considered significant.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">The demographic and clinical information of all participants.</div>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><tbody><tr><td valign="top"/><td valign="top">D-PD (n = 59)</td><td valign="top">ND-PD (n = 97)</td><td valign="top">HC (n = 45)</td><td valign="top">P value</td></tr><tr><td valign="top">Age (years)</td><td valign="top">57.6 ± 10.7 (41 - 75)</td><td valign="top">61.2 ± 9.5 (44 - 79)</td><td valign="top">59.4 ± 10.0 (45 - 75)</td><td valign="top">0.092???,???</td></tr><tr><td valign="top">Sex (M/FM)</td><td valign="top">28/31</td><td valign="top">51/46</td><td valign="top">24/21</td><td valign="top">0.77???</td></tr><tr><td valign="top">PD duration (years)</td><td valign="top">9.5 ± 2.9 (5 - 14)</td><td valign="top">7.8 ± 2.4 (5 - 12)</td><td valign="top">NA</td><td valign="top">0.001???</td></tr><tr><td valign="top">LEDD</td><td valign="top">1056.4 ± 483.6 (250 - 1750)</td><td valign="top">1004.8 ± 452.9 (250 - 1750)</td><td valign="top">NA</td><td valign="top">0.43???</td></tr><tr><td valign="top">UPDRS III</td><td valign="top">46.4 ± 15.2 (30 - 81)</td><td valign="top">44.6 ± 13.5 (23.5 - 76)</td><td valign="top">NA</td><td valign="top">0.48???</td></tr><tr><td valign="top">HDRS</td><td valign="top">24.1 ± 10.5 (12 - 54)</td><td valign="top">13.9 ± 6.7 (2 - 24)</td><td valign="top">6.7 ± 4.6 (0 - 15)</td><td valign="top">&lt; 0.001???,???</td></tr><tr><td valign="top">BDI</td><td valign="top">21.5 ± 11.1 (9 - 48)</td><td valign="top">8.1 ± 6.2 (2 - 20)</td><td valign="top">4.9 ± 3.5 (0 - 12)</td><td valign="top">&lt; 0.001???,???</td></tr><tr><td valign="top">PSQI</td><td valign="top">15.7 ± 8.4 (4 - 34)</td><td valign="top">14.2 ± 7.6 (2 - 32)</td><td valign="top">12.7 ± 6.7 (1 - 26)</td><td valign="top">0.14???,???</td></tr><tr><td valign="top">MoCA</td><td valign="top">23.1 ± 5.4 (14 - 30)</td><td valign="top">24.2 ± 4.6 (15 - 30)</td><td valign="top">26.9 ± 2.4 (26 - 30)</td><td valign="top">&lt; 0.001???,???</td></tr><tr><td valign="top">MMSE</td><td valign="top">26.9 ± 3.1 (20 - 30)</td><td valign="top">27.6 ± 2.8 (22 - 30)</td><td valign="top">28.2 ± 2.1 (26 - 30)</td><td valign="top">0.065???,???</td></tr></tbody></table></div>BDI = Beck Depression Inventory, D-PD = depressed PD, FM = female, HC = healthy controls, HDRS = Hamilton Depression Rating Scale, LEDD = levodopa equivalent daily dose, M = male, MMSE = Mini-Mental State Examination, MoCA = Montreal Cognitive Assessment Scale, NA = not applicable, ND-PD = non-depressed PD, PSQI = Pittsburgh Sleep Quality Index, UPDRS III = Unified Parkinson's Disease Rating Scale part III.Values are represented as the mean ± standard deviation with the range in parentheses, except for the gender distribution. For comparisons of demographic and clinical characteristics:.⁎P values were calculated with One-way ANOVA tests.†P value was obtained using a chi-squared test.‡P values were calculated with two-tailed t tests.aPost-hoc paired comparisons showed no significant differences between each two of the three groups.bPost-hoc paired comparisons showed significant differences between each two of the three groups.cPost-hoc paired comparisons showed significant differences between D-PD and HC, and between ND-PD and HC. P &lt; 0.05 was considered significant.</transformed-table></extracted-table><extracted-table><table-id>tbl0002</table-id><table-label>Table 2</table-label><table-caption>Significantly relevant FC features to discriminate depressed and non-depressed PD patients.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" position="float" id="tbl0002"><label>Table 2</label><caption><p>Significantly relevant FC features to discriminate depressed and non-depressed PD patients.</p></caption><alt-text id="alt0005">Table 2</alt-text><table frame="hsides" rules="groups"><tbody><tr><td valign="top">Selection Frequency (%)<xref rid="tb2fn1" ref-type="table-fn">*</xref></td><td valign="top">Feature Description</td><td valign="top">D-PD</td><td valign="top">ND-PD</td><td valign="top">HC</td></tr><tr><td valign="top">91.1</td><td valign="top">FC within PCC (ICN14)</td><td valign="top">2.63 ± 0.03</td><td valign="top">2.31 ± 0.02</td><td valign="top">2.22 ± 0.02</td></tr><tr><td valign="top">90.3</td><td valign="top">FC between insula (ICN17) and PCC (ICN14)</td><td valign="top">−0.25 ± 0.16</td><td valign="top">−0.56 ± 0.31</td><td valign="top">−0.46 ± 0.28</td></tr><tr><td valign="top">88.4</td><td valign="top">FC between insula (ICN17) and precuneus (ICN35)</td><td valign="top">−0.27 ± 0.23</td><td valign="top">−0.47 ± 0.33</td><td valign="top">−0.42 ± 0.31</td></tr><tr><td valign="top">86.1</td><td valign="top">FC within insula (ICN17)</td><td valign="top">2.25 ± 0.02</td><td valign="top">2.56 ± 0.02</td><td valign="top">2.64 ± 0.03</td></tr><tr><td valign="top">82.1</td><td valign="top">FC between PCC (ICN14) and hippocampus+amygdala (ICN47)</td><td valign="top">−0.39 ± 0.23</td><td valign="top">−0.24 ± 0.22</td><td valign="top">−0.11 ± 0.10</td></tr><tr><td valign="top">80.7</td><td valign="top">FC between SPL (ICN15) and mPFC (ICN27)</td><td valign="top">0.34 ± 0.21</td><td valign="top">0.22 ± 0.16</td><td valign="top">0.11 ± 0.09</td></tr></tbody></table><table-wrap-foot><fn id="spara008"><p>D-PD = depressed PD, FC = functional connectivity, HC = healthy controls, mPFC = medial prefrontal cortex, ND-PD = non-depressed PD, PCC = posterior cingulate cortex, SPL = superior parietal lobule.</p></fn><fn id="spara009"><p>Values are represented as the mean ± standard deviation, except for the selection frequency.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tb2fn1"><label>⁎</label><p id="notep0012">Defined as the number of iterations in which the feature was selected divided by the total number of iterations performed.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Significantly relevant FC features to discriminate depressed and non-depressed PD patients.</div>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><tbody><tr><td valign="top">Selection Frequency (%)???</td><td valign="top">Feature Description</td><td valign="top">D-PD</td><td valign="top">ND-PD</td><td valign="top">HC</td></tr><tr><td valign="top">91.1</td><td valign="top">FC within PCC (ICN14)</td><td valign="top">2.63 ± 0.03</td><td valign="top">2.31 ± 0.02</td><td valign="top">2.22 ± 0.02</td></tr><tr><td valign="top">90.3</td><td valign="top">FC between insula (ICN17) and PCC (ICN14)</td><td valign="top">−0.25 ± 0.16</td><td valign="top">−0.56 ± 0.31</td><td valign="top">−0.46 ± 0.28</td></tr><tr><td valign="top">88.4</td><td valign="top">FC between insula (ICN17) and precuneus (ICN35)</td><td valign="top">−0.27 ± 0.23</td><td valign="top">−0.47 ± 0.33</td><td valign="top">−0.42 ± 0.31</td></tr><tr><td valign="top">86.1</td><td valign="top">FC within insula (ICN17)</td><td valign="top">2.25 ± 0.02</td><td valign="top">2.56 ± 0.02</td><td valign="top">2.64 ± 0.03</td></tr><tr><td valign="top">82.1</td><td valign="top">FC between PCC (ICN14) and hippocampus+amygdala (ICN47)</td><td valign="top">−0.39 ± 0.23</td><td valign="top">−0.24 ± 0.22</td><td valign="top">−0.11 ± 0.10</td></tr><tr><td valign="top">80.7</td><td valign="top">FC between SPL (ICN15) and mPFC (ICN27)</td><td valign="top">0.34 ± 0.21</td><td valign="top">0.22 ± 0.16</td><td valign="top">0.11 ± 0.09</td></tr></tbody></table></div>D-PD = depressed PD, FC = functional connectivity, HC = healthy controls, mPFC = medial prefrontal cortex, ND-PD = non-depressed PD, PCC = posterior cingulate cortex, SPL = superior parietal lobule.Values are represented as the mean ± standard deviation, except for the selection frequency.⁎Defined as the number of iterations in which the feature was selected divided by the total number of iterations performed.</transformed-table></extracted-table></extracted-tables-set>